Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.

about

Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice.Risk factors associated with post–kidney transplant malignancies: an article from the Cancer-Kidney International Network.

P2860

Q47846456-A3AF51AC-0D37-420D-A609-41F575BD8931 Q55266341-E56FAD93-7B82-491E-A44B-4C85DF3E93D5

P2860

Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.

Item

http://www.wikidata.org/entity/Q38892578

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.

@en

type

Item

label

Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.

@en

prefLabel

Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.

@en

P1476

Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.

@en

P2093

Alexander S Hill

http://www.w3.org/2001/XMLSchema#string

Bijan A Niknam

http://www.w3.org/2001/XMLSchema#string

Deirdre Sawinski

http://www.w3.org/2001/XMLSchema#string

Jeffrey H Silber

http://www.w3.org/2001/XMLSchema#string

Jesse D Schold

http://www.w3.org/2001/XMLSchema#string

Mary Ann Lim

http://www.w3.org/2001/XMLSchema#string

Neel Koyawala

http://www.w3.org/2001/XMLSchema#string

Orit Even-Shoshan

http://www.w3.org/2001/XMLSchema#string

Paul R Rosenbaum

http://www.w3.org/2001/XMLSchema#string

Peter P Reese

http://www.w3.org/2001/XMLSchema#string

P2860

Azathioprine and UVA light generate mutagenic oxidative DNA damage

Selection of induction therapy in kidney transplantation

Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States

Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin.

Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants.

The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data. Anti-Lymphocyte Antibody Induction Therapy Study Group.

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.

Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation.

Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data.

Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.

P304

2188-2200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2016070768

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joseph G Reiter

Jennifer Trofe-Clark

P577

2017-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28320767

http://www.w3.org/2001/XMLSchema#string

P932

5491281

http://www.w3.org/2001/XMLSchema#string

Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.

about

P2860

P2860

Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932